Interactions between sirtuins and fluorogenic small-molecule substrates offer insights into inhibitor design

Hua-Li Wang, Sha Liu, Zhu-Jun Yu, Chengyong Wu, Linna Cheng, Yuxi Wang, Kai Chen, Shu Zhou, Qiang Chen, Yamei Yu and Guo-Bo Li

RSC Adv., 2017, 7, 36214
DOI: 10.1039/C7RA05824A

α-Aminophosphonate inhibitors of metallo-β-lactamases NDM-1 and VIM-2

Katarzyna Palica, Fritz Deufel, Susann Skagseth, Gabriela Paula Di Santo Metzler, Johannes Thoma, Anna Andersson Rasmussen, Arto Valkonen, Per Sunnerhagen, Hanna-Kirsti S. Leiros, Hanna Andersson and Mate Erdelyi

RSC Med. Chem., 2023, 14, 2277
DOI: 10.1039/D3MD00286A

Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors

Yu-Hang Yan, Jian Chen, Zhen Zhan, Zhu-Jun Yu, Gen Li, Li Guo, Guo-Bo Li, Yong Wu and Yongxiang Zheng

RSC Adv., 2020, 10, 31377
DOI: 10.1039/D0RA06405J

Structure-based discovery of new maternal embryonic leucine zipper kinase inhibitors

Shu Zhou, Guo-Bo Li, Lin Luo, Lei Zhong, Kai Chen, Hui Li, Xiao-Juan Jiang, Qi Fu, Xin Long and Jin-ku Bao

Org. Biomol. Chem., 2018, 16, 1489
DOI: 10.1039/C7OB02344H

Rh(iii)-Catalyzed directed C–H carbenoid coupling reveals aromatic bisphosphonates inhibiting metallo- and Serine-β-lactamases

Chen Zhang, Yan-chi Pu, Zhu-Jun Yu, Cheng-yong Wu, Jürgen Brem, Michael A. McDonough, Christopher J. Schofield, Guo-Bo Li and Yong Wu

Org. Chem. Front., 2018, 5, 1288
DOI: 10.1039/C8QO00009C

The effect of bisphenol A on testicular steroidogenesis and its amelioration by quercetin: anin vivoandin silicoapproach

Sanman Samova, Chirag N. Patel, Hetal Doctor, Himanshu A. Pandya and R. J. Verma

Toxicol. Res., 2018, 7, 22
DOI: 10.1039/C7TX00161D

Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition

Guo-Bo Li, Jürgen Brem, Robert Lesniak, Martine I. Abboud, Christopher T. Lohans, Ian J. Clifton, Sheng-Yong Yang, Juan-Carlos Jiménez-Castellanos, Matthew B. Avison, James Spencer, Michael A. McDonough and Christopher J. Schofield

Chem. Commun., 2017, 53, 5806
DOI: 10.1039/C7CC02394D

β-lactam/β-lactamase inhibitor combinations: an update

Kamaleddin H. M. E. Tehrani and Nathaniel I. Martin

Med. Chem. Commun., 2018, 9, 1439
DOI: 10.1039/C8MD00342D

Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases

Jung Hun Lee, Sang-Gyu Kim, Kyung-Min Jang, Kyoungmin Shin, Hyeonku Jin, Dae-Wi Kim, Byeong Chul Jeong and Sang Hee Lee

Journal of Enzyme Inhibition and Medicinal Chemistry, 2024, 39
DOI: 10.1080/14756366.2024.2318830

New techniques and strategies in drug discovery

Jintong Du, Jing Guo, Dongwei Kang, Zhihong Li, Guan Wang, Jianbing Wu, Zhen Zhang, Hao Fang, Xuben Hou, Zhangjian Huang, Guobo Li, Xiaoyun Lu, Xinyong Liu, Liang Ouyang, Li Rao, Peng Zhan, Xiaojin Zhang and Yihua Zhang

Chinese Chemical Letters, 2020, 31, 1695
DOI: 10.1016/j.cclet.2020.03.028

Recent advances in β-lactamase inhibitor chemotypes and inhibition modes

Rong Li, Xi Chen, Cong Zhou, Qing-Qing Dai and Lingling Yang

European Journal of Medicinal Chemistry, 2022, 242, 114677
DOI: 10.1016/j.ejmech.2022.114677

Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance

Yu‐Hang Yan, Gen Li and Guo‐Bo Li

Medicinal Research Reviews, 2020, 40, 1558
DOI: 10.1002/med.21665

((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies

Sha Liu, Li Jing, Zhu-Jun Yu, Chengyong Wu, Yongxiang Zheng, En Zhang, Qiang Chen, Yamei Yu, Li Guo, Yong Wu and Guo-Bo Li

European Journal of Medicinal Chemistry, 2018, 145, 649
DOI: 10.1016/j.ejmech.2018.01.032

Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors

Rong Li, Huilin Su, Wei Chen, Yu-Hang Yan, Cong Zhou, Luohe Mou, Huan Yang, Shan Qian, Zhouyu Wang, Lingling Yang and Guo-Bo Li

Bioorganic & Medicinal Chemistry, 2022, 72, 116993
DOI: 10.1016/j.bmc.2022.116993

Citrinal B, natural 11 beta-hydroxysteroid dehydrogennase type 1 inhibitor identified from structure-based virtual screening

Jie Cao, Limin Gao, Yizhan Chen, Weiguang Sun, Fuqian Wang, Hua Li and Yonghui Zhang

Fitoterapia, 2017, 123, 29
DOI: 10.1016/j.fitote.2017.09.018

In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors

Ricky Cain, Jürgen Brem, David Zollman, Michael A. McDonough, Rachel M. Johnson, James Spencer, Anne Makena, Martine I. Abboud, Samuel Cahill, Sook Y. Lee, Peter J. McHugh, Christopher J. Schofield and Colin W. G. Fishwick

J. Med. Chem., 2018, 61, 1255
DOI: 10.1021/acs.jmedchem.7b01728

Spodium Bonds in Biological Systems: Expanding the Role of Zn in Protein Structure and Function

Himansu S. Biswal, Akshay Kumar Sahu, Antonio Frontera and Antonio Bauzá

J. Chem. Inf. Model., 2021, 61, 3945
DOI: 10.1021/acs.jcim.1c00594

Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?

Axel Dalhoff

Infection, 2021, 49, 569
DOI: 10.1007/s15010-020-01547-9

Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem

Kamaleddin Haj Mohammad Ebrahim Tehrani and Nathaniel I. Martin

ACS Infect. Dis., 2017, 3, 711
DOI: 10.1021/acsinfecdis.7b00094

Cross-subclass metallo-β-lactamase inhibitors: From structural and catalytic commonalities guiding design

Yanhong Zhang, Zhenyang Liang, Shuai Wang, Renzhong Qiao and Chao Li

European Journal of Medicinal Chemistry, 2025, 289, 117479
DOI: 10.1016/j.ejmech.2025.117479

Approaches for the discovery of metallo‐β‐lactamase inhibitors: A review

Cheng Shi, Jiaxing Chen, Xinyue Kang, Xutong Shen, Xingzhen Lao and Heng Zheng

Chem Biol Drug Des, 2019, 94, 1427
DOI: 10.1111/cbdd.13526

Structure-Based Development of (1-(3′-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases

Yao-Ling Wang, Sha Liu, Zhu-Jun Yu, Yuan Lei, Meng-Yi Huang, Yu-Hang Yan, Qiang Ma, Yang Zheng, Hui Deng, Ying Sun, Chengyong Wu, Yamei Yu, Qiang Chen, Zhenling Wang, Yong Wu and Guo-Bo Li

J. Med. Chem., 2019, 62, 7160
DOI: 10.1021/acs.jmedchem.9b00735

Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors

Yu-Hang Yan, Wenfang Li, Wei Chen, Chao Li, Kai-Rong Zhu, Ji Deng, Qing-Qing Dai, Ling-Ling Yang, Zhenling Wang and Guo-Bo Li

European Journal of Medicinal Chemistry, 2022, 228, 113965
DOI: 10.1016/j.ejmech.2021.113965

Discovery of 2-Aminothiazole-4-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors by Mimicking Carbapenem Hydrolysate Binding

Yu-Hang Yan, Ting-Ting Zhang, Rong Li, Si-Yao Wang, Liu-Liu Wei, Xin-Yue Wang, Kai-Rong Zhu, Shan-Rui Li, Guo-Qing Liang, Zeng-Bao Yang, Ling-Ling Yang, Shangshang Qin and Guo-Bo Li

J. Med. Chem., 2023, 66, 13746
DOI: 10.1021/acs.jmedchem.3c01189

Progress Toward Inhibitors of Metallo-β-Lactamases

Ross P McGeary, Daniel TC Tan and Gerhard Schenk

Future Med. Chem., 2017, 9, 673
DOI: 10.4155/fmc-2017-0007

H2dpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing Enterobacterales

Fangfang Chen, Mengmeng Bai, Wentian Liu, Hongtao Kong, Tingting Zhang, Hong Yao, En Zhang, Juan Du and Shangshang Qin

European Journal of Medicinal Chemistry, 2021, 224, 113702
DOI: 10.1016/j.ejmech.2021.113702

Structural Insights for Core Scaffold and Substrate Specificity of B1, B2, and B3 Metallo-β-Lactamases

Yeongjin Yun, Sangjun Han, Yoon Sik Park, Hyunjae Park, Dogyeong Kim, Yeseul Kim, Yongdae Kwon, Sumin Kim, Jung Hun Lee, Jeong Ho Jeon, Sang Hee Lee and Lin-Woo Kang

Front. Microbiol., 2022, 12
DOI: 10.3389/fmicb.2021.752535

Virtual target screening reveals rosmarinic acid and salvianolic acid A inhibiting metallo- and serine-β-lactamases

Zhu-Jun Yu, Sha Liu, Shu Zhou, Hui Li, Fan Yang, Ling-Ling Yang, Yong Wu, Li Guo and Guo-Bo Li

Bioorganic & Medicinal Chemistry Letters, 2018, 28, 1037
DOI: 10.1016/j.bmcl.2018.02.025

#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models

Wen-Jie Lu, Wen Peng, Qian-Qian Sun, Yong-Huai Li, Bo Chen, Luo-Ting Yu, You-Zhi Xu, Si-Ying Wang and Ying-Lan Zhao

Cell Death Discovery, 2018, 4
DOI: 10.1038/s41420-018-0032-y

Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery

Yongqiang Yang, Yu-Hang Yan, Christopher J. Schofield, Alan McNally, Zhiyong Zong and Guo-Bo Li

Trends in Microbiology, 2023, 31, 735
DOI: 10.1016/j.tim.2023.01.013

Insight into Structure-Function Relationships of β-Lactamase and BLIPs Interface Plasticity using Protein-Protein Interactions

Tara C. Yadav, Vidhu Agarwal, Amit K. Srivastava, Navdeep Raghuwanshi, Pritish Varadwaj, Ramasare Prasad and Vikas Pruthi

CPD, 2019, 25, 3378
DOI: 10.2174/1381612825666190911154650

X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells

Ling-Ling Yang, Hua-Li Wang, Lei Zhong, Chen Yuan, Si-Yu Liu, Zhu-Jun Yu, Sha Liu, Yu-Hang Yan, Chengyong Wu, Yuxi Wang, Zhouyu Wang, Yamei Yu, Qiang Chen and Guo-Bo Li

European Journal of Medicinal Chemistry, 2018, 155, 806
DOI: 10.1016/j.ejmech.2018.06.041

AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases

Qingqing Dai, Yuhang Yan, Xiangli Ning, Gen Li, Junlin Yu, Ji Deng, Lingling Yang and Guo-Bo Li

Acta Pharmaceutica Sinica B, 2021, 11, 1931
DOI: 10.1016/j.apsb.2021.01.018

Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design

Pasquale Linciano, Laura Cendron, Eleonora Gianquinto, Francesca Spyrakis and Donatella Tondi

ACS Infect. Dis., 2019, 5, 9
DOI: 10.1021/acsinfecdis.8b00247

Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein

Warawan Eiamphungporn, Nalini Schaduangrat, Aijaz Ahmad Malik and Chanin Nantasenamat

IJMS, 2018, 19, 2222
DOI: 10.3390/ijms19082222

Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism

Antonela R. Palacios, María-Agustina Rossi, Graciela S. Mahler and Alejandro J. Vila

Biomolecules, 2020, 10, 854
DOI: 10.3390/biom10060854

Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases

Orville A. Pemberton, Priyadarshini Jaishankar, Afroza Akhtar, Jessie L. Adams, Lindsey N. Shaw, Adam R. Renslo and Yu Chen

J. Med. Chem., 2019, 62, 8480
DOI: 10.1021/acs.jmedchem.9b00728

YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect

Qian Lei, Lu Xiong, Yong Xia, Zhanzhan Feng, Tiantao Gao, Wei Wei, Xuejiao Song, Tinghong Ye, Ningyu Wang, Cuiting Peng, Zhongping Li, Zhihao Liu and Luoting Yu

Cell Death Dis, 2018, 9
DOI: 10.1038/s41419-018-1071-2

Drug Discovery in the Field of β-Lactams: An Academic Perspective

Lian M. C. Jacobs, Patrick Consol and Yu Chen

Antibiotics, 2024, 13, 59
DOI: 10.3390/antibiotics13010059

MeLAD: an integrated resource for metalloenzyme-ligand associations

Gen Li, Yu Su, Yu-Hang Yan, Jia-Yi Peng, Qing-Qing Dai, Xiang-Li Ning, Cheng-Long Zhu, Chen Fu, Michael A McDonough, Christopher J Schofield, Cheng Huang, Guo-Bo Li and Jonathan Wren

Bioinformatics, 2020, 36, 904
DOI: 10.1093/bioinformatics/btz648

Ruthenium‐Catalyzed meta‐Selective C−H Nitration of Biologically Important Aryltetrazoles

Jian Chen, Tianle Huang, Xinrui Gong, Zhu‐Jun Yu, Yuesen Shi, Yu‐Hang Yan, Yang Zheng, Xuexin Liu, Guo‐Bo Li and Yong Wu

Adv Synth Catal, 2020, 362, 2984
DOI: 10.1002/adsc.202000475

Rosavin derived from Rhodiola alleviates colitis in mice through modulation of Th17 differentiation

Yi Wang, Yu Jiang, Mingxing Li, Yaqin Xiao, Qianyun Zhao, Jiuping Zeng, Shulin Wei, Shuhan Chen, Yueshui Zhao, Fukuan Du, Yu Chen, Shuai Deng, Jing Shen, Xiaobing Li, Wanping Li, Fang Wang, Yuhong Sun, Li Gu, Zhangang Xiao, Shengpeng Wang and Xu Wu

Phytomedicine, 2025, 136, 156318
DOI: 10.1016/j.phymed.2024.156318

Identification of Cisplatin and Palladium(II) Complexes as Potent Metallo-β-lactamase Inhibitors for Targeting Carbapenem-Resistant Enterobacteriaceae

Cheng Chen, Le-Yun Sun, Han Gao, Peng-Wei Kang, Jia-Qi Li, Jian-Bin Zhen and Ke-Wu Yang

ACS Infect. Dis., 2020, 6, 975
DOI: 10.1021/acsinfecdis.9b00385

Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors

Yu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, Bin-Song Mu, Yang Zheng, Meng-Yi Huang, Cong Zhou, Wen-Fang Li, Zhenling Wang, Yong Wu and Guo-Bo Li

European Journal of Medicinal Chemistry, 2023, 257, 115473
DOI: 10.1016/j.ejmech.2023.115473

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

Catherine L. Tooke, Philip Hinchliffe, Eilis C. Bragginton, Charlotte K. Colenso, Viivi H.A. Hirvonen, Yuiko Takebayashi and James Spencer

Journal of Molecular Biology, 2019, 431, 3472
DOI: 10.1016/j.jmb.2019.04.002

Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design

Guillermo Bahr, Lisandro J. González and Alejandro J. Vila

Chem. Rev., 2021, 121, 7957
DOI: 10.1021/acs.chemrev.1c00138

IFPTarget: A Customized Virtual Target Identification Method Based on Protein–Ligand Interaction Fingerprinting Analyses

Guo-Bo Li, Zhu-Jun Yu, Sha Liu, Lu-Yi Huang, Ling-Ling Yang, Christopher T. Lohans and Sheng-Yong Yang

J. Chem. Inf. Model., 2017, 57, 1640
DOI: 10.1021/acs.jcim.7b00225

Total Synthesis and Evaluation of B‐Homo Palmatine and Berberine Derivatives as p300 Histone Acetyltransferase Inhibitors

Zhongzhen Yang, Yong Zhang, Xin Chen, Weijian Li, Guo‐Bo Li and Yong Wu

Eur J Org Chem, 2018, 2018, 1041
DOI: 10.1002/ejoc.201701693

NMR as a “Gold Standard” Method in Drug Design and Discovery

Abdul-Hamid Emwas, Kacper Szczepski, Benjamin Gabriel Poulson, Kousik Chandra, Ryan T. McKay, Manel Dhahri, Fatimah Alahmari, Lukasz Jaremko, Joanna Izabela Lachowicz and Mariusz Jaremko

Molecules, 2020, 25, 4597
DOI: 10.3390/molecules25204597

Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases

Dong Zhang, Marios S. Markoulides, Dmitrijs Stepanovs, Anna M. Rydzik, Ahmed El-Hussein, Corentin Bon, Jos J.A.G. Kamps, Klaus-Daniel Umland, Patrick M. Collins, Samuel T. Cahill, David Y. Wang, Frank von Delft, Jürgen Brem, Michael A. McDonough and Christopher J. Schofield

Bioorganic & Medicinal Chemistry, 2018, 26, 2928
DOI: 10.1016/j.bmc.2018.02.043

Worldwide trend discovery of structural and functional relationship of metallo-β-lactamase for structure-based drug design: A bibliometric evaluation and patent analysis

Ameera Aisyah Azman, Adam Thean Chor Leow, Noor Dina Muhd Noor, Siti Aminah Mohd Noor, Wahhida Latip and Mohd Shukuri Mohamad Ali

International Journal of Biological Macromolecules, 2024, 256, 128230
DOI: 10.1016/j.ijbiomac.2023.128230

Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors

Chen Yuan, Jie Yan, Chen Song, Fan Yang, Chao Li, Cheng Wang, Huiling Su, Wei Chen, Lijiao Wang, Zhouyu Wang, Shan Qian and Lingling Yang

Molecules, 2019, 25, 56
DOI: 10.3390/molecules25010056

Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors

Shuo Yuan, Bo Wang, Qing-Qing Dai, Xiao-Nan Zhang, Jing-Ya Zhang, Jia-Hui Zuo, Hui Liu, Zhe-Sheng Chen, Guo-Bo Li, Shaomeng Wang, Hong-Min Liu and Bin Yu

J. Med. Chem., 2021, 64, 14895
DOI: 10.1021/acs.jmedchem.1c01452

Structure‐based discovery of new selective small‐molecule sirtuin 5 inhibitors

Sha Liu, Sen Ji, Zhu‐Jun Yu, Hua‐Li Wang, Xu Cheng, Wei‐Jian Li, Li Jing, Yamei Yu, Qiang Chen, Ling‐Ling Yang, Guo‐Bo Li and Yong Wu

Chem Biol Drug Des, 2018, 91, 257
DOI: 10.1111/cbdd.13077

Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases

Yu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, Ji Deng, Jun-Lin Yu, Yubin Luo, Zhenling Wang, Guo Li, Guo-Bo Li and You-Cai Xiao

Bioorganic & Medicinal Chemistry Letters, 2021, 41, 127956
DOI: 10.1016/j.bmcl.2021.127956

Molecules that Inhibit Bacterial Resistance Enzymes

Yuan Liu, Ruichao Li, Xia Xiao and Zhiqiang Wang

Molecules, 2018, 24, 43
DOI: 10.3390/molecules24010043

Addressing Antimicrobial Resistance through New Medicinal and Synthetic Chemistry Strategies

Monika I. Konaklieva

SLAS Discovery, 2019, 24, 419
DOI: 10.1177/2472555218812657

PyPLIF HIPPOS: A Molecular Interaction Fingerprinting Tool for Docking Results of AutoDock Vina and PLANTS

Enade P. Istyastono, Muhammad Radifar, Nunung Yuniarti, Vivitri D. Prasasty and Sudi Mungkasi

J. Chem. Inf. Model., 2020, 60, 3697
DOI: 10.1021/acs.jcim.0c00305

Efficient synthesis of β-lactam antibiotics with in situ product removal by a newly isolated penicillin G acylase

Xin Pan, Anni Li, Zhiyi Peng, Xiaoqi Ji, Jianlin Chu and Bingfang He

Bioorganic Chemistry, 2020, 99, 103765
DOI: 10.1016/j.bioorg.2020.103765

Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance

Geetika Dhanda, Yash Acharya and Jayanta Haldar

ACS Omega, 2023, 8, 10757
DOI: 10.1021/acsomega.3c00312

Inhibitors of metallo-β-lactamases

Caitlyn M Rotondo and Gerard D Wright

Current Opinion in Microbiology, 2017, 39, 96
DOI: 10.1016/j.mib.2017.10.026

Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor

Yang Xiang, Yue-Juan Zhang, Ying Ge, Yajun Zhou, Cheng Chen, Weixiao Yuan Wahlgren, Xiangshi Tan, Xi Chen and Ke-Wu Yang

Biomolecules, 2020, 10, 72
DOI: 10.3390/biom10010072